Hirtle Callaghan & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harley-Davidson
HOG
|
+$8M |
| 2 |
Teledyne Technologies
TDY
|
+$3.53M |
| 3 |
SLB Ltd
SLB
|
+$2.58M |
| 4 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$2.06M |
| 5 |
T. Rowe Price
TROW
|
+$656K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$81.3M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$21.5M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$4.55M |
| 4 |
Goldman Sachs
GS
|
+$4.54M |
| 5 |
SEI Investments
SEIC
|
+$3.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.08% |
| 2 | Financials | 6.93% |
| 3 | Energy | 6.9% |
| 4 | Technology | 5.15% |
| 5 | Healthcare | 5.03% |
Similar funds
Hirtle Callaghan & Co's Q1 2014 Portfolio in Review
As of Q1 2014, Hirtle Callaghan & Co held 716 positions worth $605M, down 19% from $747M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Hirtle Callaghan & Co withdrew a net $131M in Q1 2014, closing 76 positions and reducing 97 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $4.55M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 21% a quarter earlier, followed by Financials and Energy.
Against the trend, Hirtle Callaghan & Co opened a new position in T. Rowe Price worth $667K.
- Hirtle Callaghan & Co's largest Q1 2014 buy was T. Rowe Price: 8,100 shares worth $667K.
- Hirtle Callaghan & Co added most to Harley-Davidson in Q1 2014, an estimated $8M increase.
- Hirtle Callaghan & Co's biggest Q1 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $81.3M.
- Hirtle Callaghan & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $4.55M.
- Hirtle Callaghan & Co's ten largest holdings make up 54% of its $605M portfolio in Q1 2014.
- Hirtle Callaghan & Co opened 100 new positions and closed 76 in Q1 2014.
- Hirtle Callaghan & Co's portfolio value fell 19% quarter-over-quarter to $605M.
Based on Hirtle Callaghan & Co's 13F filing for Q1 2014, filed 2 May 2014.